Adverse Event Clinical Research R4 Backport
1.0.1 - STU1 International flag

This page is part of the Adverse Event Clinical Research R4 Backport (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: medication-administration-kadcyla-reduced - XML Representation

Page standards status: Informative

Raw xml | Download



<MedicationAdministration xmlns="http://hl7.org/fhir">
  <id value="medication-administration-kadcyla-reduced"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationAdministration</b><a name="medication-administration-kadcyla-reduced"> </a><a name="hcmedication-administration-kadcyla-reduced"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationAdministration &quot;medication-administration-kadcyla-reduced&quot; </p></div><p><b>status</b>: completed</p><p><b>medication</b>: KADCYLA <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#1371046)</span></p><p><b>subject</b>: <a href="Patient-patient-example-kaitlyn-b.html">Patient/patient-example-kaitlyn-b</a> &quot; BOUNCE&quot;</p><p><b>effective</b>: 2020-05-20</p><h3>Performers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Actor</b></td></tr><tr><td style="display: none">*</td><td><a href="Practitioner-practitioner-oncology-nurse-jane.html">Practitioner/practitioner-oncology-nurse-jane</a> &quot; NURSE&quot;</td></tr></table><p><b>request</b>: <a href="MedicationRequest-medication-request-example-kadcyla.html">MedicationRequest/medication-request-example-kadcyla</a></p><p><b>note</b>: reduced dose of 3.0mg administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/practitioner-oncology-nurse-jane @2020-05-20)</p><h3>Dosages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td style="display: none">*</td><td>Intravenous route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#47625008)</span></td><td>3 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></td></tr></table></div>
  </text>
  <status value="completed"/>
  <medicationCodeableConcept>
    <coding>
      <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
      <code value="1371046"/>
      <display value="KADCYLA"/>
    </coding>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/patient-example-kaitlyn-b"/>
  </subject>
  <effectiveDateTime value="2020-05-20"/>
  <performer>
    <actor>🔗 
      <reference value="Practitioner/practitioner-oncology-nurse-jane"/>
    </actor>
  </performer>
  <request>🔗 
    <reference value="MedicationRequest/medication-request-example-kadcyla"/>
  </request>
  <note>
    <authorReference>🔗 
      <reference value="Practitioner/practitioner-oncology-nurse-jane"/>
    </authorReference>
    <time value="2020-05-20"/>
    <text
          value="reduced dose of 3.0mg administered by continuous infusion. Patient tolerated infusion without side effects."/>
  </note>
  <dosage>
    <route>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="47625008"/>
        <display value="Intravenous route (qualifier value)"/>
      </coding>
    </route>
    <dose>
      <value value="3"/>
      <unit value="mg"/>
      <system value="http://unitsofmeasure.org"/>
      <code value="mg"/>
    </dose>
  </dosage>
</MedicationAdministration>